First Light Diagnostics Overview
- Founded
-
2006
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$992K
- Investors
-
17
First Light Diagnostics General Information
Description
Developer of innovative diagnostic tests designed to enable rapid and accurate detection of pathogens that can cause life-threatening infections. The company's antimicrobial susceptibility tests ensure that patients suffering from infection receive appropriate antibiotic treatment options in hours and not days compared to current practices, helping medical professionals to save lives, lower healthcare costs, improve antibiotic stewardship, and prevent the spread of antibiotic drugs resistance.
Contact Information
Website
www.firstlightdx.com
Formerly Known As
First Light Biosciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
- 2 Omni Way
- Chelmsford, MA 01824
- United States
+1 (781) 000-0000
First Light Diagnostics Timeline
First Light Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Grant | 01-Apr-2021 | $992K | 0000 | Completed | Generating Revenue | |
| 13. Debt - PPP | 15-Apr-2020 | 00.00 | 0000 | Completed | Generating Revenue | |
| 12. Debt - General | 00.00 | 0000 | Completed | Generating Revenue | ||
| 11. Debt - General | 19-Jun-2019 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 10. Later Stage VC (Series A2) | 28-May-2019 | 000 | 0000 | 000.00 | Completed | Generating Revenue |
| 9. Later Stage VC (Series A2) | 16-Jan-2019 | 000 | 000 | 000.00 | Completed | Generating Revenue |
| 8. Later Stage VC (Series A1) | 24-Jan-2017 | 00.000 | 00.000 | 000.00 | Completed | Generating Revenue |
| 7. Debt - General | 26-May-2016 | 00000 | 00.000 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series A) | 12-Sep-2015 | $3.5M | $3.5M | 00.000 | Completed | Generating Revenue |
| 5. Grant | 01-Feb-2015 | $4M | Completed | Generating Revenue |
First Light Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | 00,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series A-1 | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 0.000 |
| Series A | 8,770,951 | $0.001000 | $0.03 | $0.43 | $0.43 | 1x | $0.43 | 16.09% |
First Light Diagnostics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of innovative diagnostic tests designed to enable rapid and accurate detection of pathogens that can cause lif
Diagnostic Equipment
Chelmsford, MA
31
As of 2022
0000
0000000000
0000
000000
ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
0000000000 000000000
Espoo, Finland
000
As of 0000
000.00
0000
0000-00-00
000000&0
000.00
000000
s nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
Leuven, Belgium
000
As of 0000
00000
000000000
00000
Add Comparison
First Light Diagnostics Competitors (17)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Mobidiag | Formerly PE-Backed | Espoo, Finland | 000 | 000.00 | 000000&0 | 000.00 |
| 0000000000000 | Venture Capital-Backed | Leuven, Belgium | 000 | 00000 | 000000000 | 00000 |
| 0000000 000000 | Venture Capital-Backed | San Diego, CA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000000 | Formerly VC-backed | Dublin, Ireland | 00 | 00.000 | 000000&0 | 00.000 |
| 00000000 | Venture Capital-Backed | San Diego, CA | 00 | 00000 | 00000000000 | 00000 |
First Light Diagnostics Patents
First Light Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3781030-A4 | Detection of targets | Pending | 19-Apr-2019 | ||
| AU-2019354837-A1 | Test cartridges | Pending | 04-Oct-2018 | 000000000000 | |
| AU-2019354837-A2 | Test cartridges | Pending | 04-Oct-2018 | 000000000000 | |
| AU-2019355198-A2 | Detection and analysis of cells | Pending | 04-Oct-2018 | 000000000000 | |
| CA-3115279-A1 | Analysis instrument | Pending | 04-Oct-2018 | G01N33/54333 |
First Light Diagnostics Executive Team (10)
First Light Diagnostics Board Members (14)
| Name | Representing | Role | Since |
|---|---|---|---|
| Donald Straus Ph.D | First Light Diagnostics | Founder, Chief Scientific Officer & Board Member | 000 0000 |
| Florian Kainzinger Ph.D | Self | Board Observer | 000 0000 |
| Norman Gitis Ph.D | Self | Board Observer | 000 0000 |
| Peter Kaspar Ph.D | First Light Diagnostics | Board Member | 000 0000 |
| Salvatore Salamone Ph.D | Self | Board Member | 000 0000 |
First Light Diagnostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
First Light Diagnostics Investors (17)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Boston Harbor Angels | Angel Group | Minority | 000 0000 | 000000 0 | |
| Launchpad Venture Group | Angel Group | Minority | 000 0000 | 000000 0 | |
| Mass Medical Angels | Venture Capital | Minority | 000 0000 | 000000 0 | |
| 10X Group | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Beacon Angels | Angel Group | Minority | 000 0000 | 000000 0 |